Quetiapine versus Clozapine in Treating Psychiatric Patients with Severe COVID-19: A Netosis-Based Opinion

Mohsen Khosravi

doi:10.29333/ejgm/11010

Full Text (PDF)

Mohsen Khosravi ¹ ^*

More Detail

¹ Department of Psychiatry and Clinical Psychology, Zahedan University of Medical Sciences, Zahedan, IRAN^* Corresponding Author

Abstract

Not applicable.

Keywords

Not applicable

License

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Article Type: Letter to Editor

ELECTRON J GEN MED, Volume 18, Issue 5, October 2021, Article No: em301

https://doi.org/10.29333/ejgm/11010

Publication date: 23 Jun 2021

Article Views: 1689

Article Downloads: 1614

Open Access References How to cite this article

References

Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020;55:105924. https://doi.org/10.1016/j.ijantimicag.2020.105924 PMID: 32081636 PMCID:PMC7127800
Chiang CC, Korinek M, Cheng WJ, Hwang TL. Targeting neutrophils to treat acute respiratory distress syndrome in Coronavirus disease. Front Pharmacol. 2020;11:572009. https://doi.org/10.3389/fphar.2020.572009 PMID: 33162887 PMCID:PMC7583590
Veras FP, Pontelli MC, Silva CM, Toller-Kawahisa JE, de Lima M, Nascimento DC, et al. SARS-CoV-2–triggered neutrophil extracellular traps mediate COVID-19 pathology. J Exp Med. 2020;217:e20201129. https://doi.org/10.1084/jem.20201129 PMID:32926098 PMCID: PMC7488868
Irizarry-Caro JA, Carmona-Rivera C, Schwartz DM, Khaznadar SS, Kaplan MJ, Grayson PC. Drugs Implicated in Systemic Autoimmunity Modulate Neutrophil Extracellular Trap Formation. Arthritis Rheumatol. 2018;70:468-74. https://doi.org/10.1002/art.40372 PMID:29121457 PMCID: PMC5826843
Colón DF, Wanderley CW, Franchin M, Silva CM, Hiroki CH, Castanheira FV, et al. Neutrophil extracellular traps (NETs) exacerbate severity of infant sepsis. Crit Care. 2019;23:113. https://doi.org/10.1186/s13054-019-2407-8 PMID:30961634 PMCID: PMC6454713
Czaikoski PG, Mota JM, Nascimento DC, Sônego F, Castanheira FV, Melo PH, et al. Neutrophil extracellular traps induce organ damage during experimental and clinical sepsis. PLoS One. 2016;11:e0148142. https://doi.org/10.1371/journal.pone.0148142 PMID:26849138 PMCID: PMC4743982
Kambas K, Mitroulis I, Apostolidou E, Girod A, Chrysanthopoulou A, Pneumatikos I, et al. Autophagy mediates the delivery of thrombogenic tissue factor to neutrophil extracellular traps in human sepsis. PLoS One. 2012;7:e45427. https://doi.org/10.1371/journal.pone.0045427 PMID: 23029002 PMCID: PMC3446899
Martinod K, Fuchs TA, Zitomersky NL, Wong SL, Demers M, et al. PAD4-deficiency does not affect bacteremia in polymicrobial sepsis and ameliorates endotoxemic shock. Blood. 2015;125:1948-56. https://doi.org/10.1182/blood-2014-07-587709 PMID:25624317 PMCID: PMC4366625
Clark SR, Ma AC, Tavener SA, McDonald B, Goodarzi Z, Kelly MM, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med. 2007;13:463-9. https://doi.org/10.1038/nm1565 PMID: 17384648
Middleton EA, He XY, Denorme F, Campbell RA, Ng D, Salvatore SP, et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020;136:1169-79. https://doi.org/10.1182/blood.2020007008 PMID: 32597954 PMCID:PMC7472714
Zuo Y, Zuo M, Yalavarthi S, Gockman K, Madison JA, Shi H, et al. Neutrophil extracellular traps and thrombosis in COVID-19. Neutrophil extracellular traps and thrombosis in COVID-19. J Thromb Thrombolysis. 2021;51:446-53. https://doi.org/10.1007/s11239-020-02324-z PMID:33151461 PMCID:PMC7642240
Skendros P, Mitsios A, Chrysanthopoulou A, Mastellos DC, Metallidis S, Rafailidis P, et al. Complement and tissue factor–enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. J Clin Invest. 2020;130:6151-6157. https://doi.org/10.1172/JCI141374 PMID:32759504 PMCID:PMC7598040
Turra BO, Barbisan F, Azzolin VF, Teixeira CF, Flores T, Braun LE, et al. Unmetabolized quetiapine exerts an in vitro effect on innate immune cells by modulating inflammatory response and neutrophil extracellular trap formation. Biomed Pharmacother. 2020;131:110497. https://doi.org/10.1016/j.biopha.2020.110497 PMID:33152899
Gee S, Gaughran F, MacCabe J, Shergill S, Whiskey E, Taylor D. Management of clozapine treatment during the COVID-19 pandemic. Ther Adv Psychopharmacol. 2020;10:2045125320928167. https://doi.org/10.1177/2045125320928167 PMID:32542111 PMCID:PMC7256815
Govind R, de Freitas DF, Pritchard M, Hayes RD, MacCabe JH. Clozapine treatment and risk of COVID-19 infection: retrospective cohort study. Br J Psychiatry. 2020;1-7. https://doi.org/10.1192/bjp.2020.151 PMID:32713374 PMCID:PMC7417985
Khosravi M. Ursodeoxycholic Acid in Patients with Treatment-Resistant Schizophrenia Suffering From Coronavirus Disease 2019: A Hypothesis Letter. Front Psychiatry. 2021;12:657316. https://doi.org/10.3389/fpsyt.2021.657316 PMID:33935842 PMCID:PMC8079749
Khosravi M. COVID-19 Pandemic: What are the Risks and Challenges for Schizophrenia?. Clin Schizophr Relat Psychoses. 2020;14:110320. https://doi.org/10.3371/CSRP.KM.110320

How to cite this article

Vancouver

Khosravi M. Quetiapine versus Clozapine in Treating Psychiatric Patients with Severe COVID-19: A Netosis-Based Opinion. ELECTRON J GEN MED. 2021;18(5):em301. https://doi.org/10.29333/ejgm/11010

APA

Khosravi, M. (2021). Quetiapine versus Clozapine in Treating Psychiatric Patients with Severe COVID-19: A Netosis-Based Opinion. Electronic Journal of General Medicine, 18(5), em301. https://doi.org/10.29333/ejgm/11010

AMA

Khosravi M. Quetiapine versus Clozapine in Treating Psychiatric Patients with Severe COVID-19: A Netosis-Based Opinion. ELECTRON J GEN MED. 2021;18(5), em301. https://doi.org/10.29333/ejgm/11010

Chicago

Khosravi, Mohsen. "Quetiapine versus Clozapine in Treating Psychiatric Patients with Severe COVID-19: A Netosis-Based Opinion". Electronic Journal of General Medicine 2021 18 no. 5 (2021): em301. https://doi.org/10.29333/ejgm/11010

Harvard

Khosravi, M. (2021). Quetiapine versus Clozapine in Treating Psychiatric Patients with Severe COVID-19: A Netosis-Based Opinion. Electronic Journal of General Medicine, 18(5), em301. https://doi.org/10.29333/ejgm/11010

MLA

Khosravi, Mohsen "Quetiapine versus Clozapine in Treating Psychiatric Patients with Severe COVID-19: A Netosis-Based Opinion". Electronic Journal of General Medicine, vol. 18, no. 5, 2021, em301. https://doi.org/10.29333/ejgm/11010